Company · CIK 0001626971
Corvus Pharmaceuticals, Inc.
CRVSSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$10.52+$0.31 (+3.04%)
CRVS · Last trade
- Prev close
- $10.21
- Range (29d)
- $10.21 – $13.44
On the record
Recent filings
- SCHEDULE 13GCRVSCorvus Pharmaceuticals, Inc.0000093751-26-000443 · 8.1 KBSEC(opens sec.gov)
- 10-QCRVSQuarterly update0001104659-26-091975 · 9.7 MBSEC(opens sec.gov)
- 8-KCRVSCurrent report0001171843-26-005317 · 281.0 KBSEC(opens sec.gov)
- SCHEDULE 13G/ACRVSCorvus Pharmaceuticals, Inc.0002012383-26-002292 · 11.0 KBSEC(opens sec.gov)
- 8-KCRVSCurrent report0001104659-26-085790 · 141.1 KBSEC(opens sec.gov)
- 8-KCRVSCurrent report0001171843-26-004094 · 194.9 KBSEC(opens sec.gov)
- 8-KCRVSCurrent report0001171843-26-003397 · 2.4 MBSEC(opens sec.gov)
- 10-QCRVSQuarterly update0001104659-26-057100 · 8.1 MBSEC(opens sec.gov)
- 8-KCRVSCurrent report0001171843-26-003154 · 275.4 KBSEC(opens sec.gov)
- 8-KCRVSCurrent report0001104659-26-047735 · 144.6 KBSEC(opens sec.gov)
Insiders
- ADAMS STREET PARTNERS LLC10% Owner
- Arcara JeffreyChief Business Officer
- Buggy Joseph JEVP, Discovery Research
- Chan Andrew C.Director
- CLARK IAN TDirector
- Coloma Jason VSVP, Chief Business Officer
- EcoR1 Capital, LLC10% Owner
- Gould Terry PDirector, 10% Owner
- Grais LindaDirector
- Hunt Daniel W.SVP, Chief Business Officer
Tickers
Addresses
business
901 GATEWAY BLVD, THIRD FLOOR
SOUTH SAN FRANCISCO, CA, 94080
mailing
901 GATEWAY BLVD, THIRD FLOOR
SOUTH SAN FRANCISCO, CA, 94080
Same industry